Author

E. Hildt

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

M. Glitscher· 3 shared C. Buske· 2 shared D. Sauter· 2 shared J. Muench· 2 shared L. M. Kaiser· 2 shared M. Harms· 2 shared D. Bender· 1 shared D. Tews· 1 shared

Activity by Year

2020-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCancer Biology

M. Glitscher

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Late stages of the Zika virus life cycle are impaired by a selective TRPML2 agonist

K. K. Schwickert, M. Glitscher, D. Bender, R. Murra, K. Schwickert, S. Pfalzgraf, T. Schirmeister, U. A. Hellmich, E. Hildt

This study shows that the TRPML2 agonist ML2-SA1 inhibits late stages of Zika virus replication by affecting genome replication and intracellular cholesterol distribution.

bioRxiv · Feb 1, 2024 · PreprintCell Biology

Acute myeloid leukemia cells are targeted by the naturally occurring CXCR4 antagonist EPI-X4

L. M. Kaiser, M. Harms, D. Sauter, V. P. S. Rawat, M. Glitscher, R. Gross, E. Hildt, J. Muench, C. Buske

The paper was withdrawn due to unresolved data contribution and authorship issues, and the authors request it not be cited as a reference.

bioRxiv · Mar 11, 2021 · PreprintCancer Biology

CXCR4 signaling is counteracted by the naturally occurring CXCR4 antagonist EPI-X 4 in Waldenstrom Macroglobulinemia

L. M. Kaiser, M. Harms, D. Sauter, V. P. Rawat, M. Glitscher, E. Hildt, D. Tews, Z. Hunter, J. Muench, C. Buske

This study shows that the natural CXCR4 antagonist EPI-X4 inhibits Waldenstrom Macroglobulinemia cell growth and migration, with optimized derivatives showing enhanced efficacy.

bioRxiv · Oct 19, 2020 · PreprintCancer Biology